iPS differentiation, disease model preparation using CRISPR/CAS technologies and licenses.
Leading company to drive AI and computational chemistry with user-friendly GUI with friendly supporting team.
Covering UK and Europe
Professional clinical study CRO having high appreciation from global clients.
iPS derived human dendritic cells for safe vaccine development for major infectious diseases including COVID and dengue.
Business development professional suitable in European countries having variety of languages.
Professional regulatory service provider being able to update the latest regulatory status in Europe and the UK.